The Bio Asia Biotechnology Exhibition will take place on July 27 at the Nangang Exhibition Center, DeepRad will also showcase its achievement, DeepLung-CAC.

DeepLung-CAC leverages cutting-edge AI technology to analyze low-dose chest CT scans. It not only detects the location of lung nodules and lesions but also predicts signs of coronary artery calcification. Moreover, the analysis results are generated in just two minutes, offering unprecedented possibilities for early detection and prevention.
Bio Asia DeepRad.AI

At the exhibition, Shen Rui Artificial Intelligence CEO Chang Yao-Chi emphasized the importance of DeepLung-CAC technology. He noted that many cardiovascular diseases show clear early signs, and DeepLung-CAC can detect these potential health issues without increasing the patient’s radiation exposure, enabling timely preventive measures.

The demonstration of DeepLung-CAC at the conference attracted widespread attention from academia, healthcare professionals, and investors. Its innovative technology and practical value added to the prominence of Shen Rui Artificial Intelligence’s debut. 

PTS Evening News-related interview link (starting at 1:05): https://www.youtube.com/watch?v=F5q9WnxwOsY&t=1s